Biofrontera AG

(NASDAQ:BFRA)

Latest On Biofrontera AG (BFRA):

Date/Time Type Description Signal Details
2022-02-14 22:25 ESTNewsBiofrontera to delist American Depositary Shares to cut costsN/A
2021-12-10 08:55 ESTNewsBiofrontera (BFRA) Investor Presentation - SlideshowN/A
2021-11-19 05:53 ESTNewsBiofrontera AG (BFRA) CEO Hermann Lübbert on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-02 04:49 ESTNewsBiofrontera reports 33% growth in September prelim revenue from product salesN/A
2021-09-08 22:41 ESTNewsBiofrontera reports 11% Y/Y growth in August prelim revenue from product salesN/A
2021-08-20 18:17 ESTNewsBiofrontera AG's (BFRA) CEO Hermann Lübbert on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-23 13:39 ESTNewsBiofrontera stock jumps 7% on Ameluz supply deal in PolandN/A
2021-07-22 17:08 ESTNewsBiofrontera reports prelim product sales revenue growth of 108% in MayN/A
2021-07-22 17:06 ESTNewsBiofrontera AG reports June revenue after Ameluz' reintroduction in ScandinaviaN/A
2021-05-07 02:08 ESTNewsBiofrontera trades in green on higher prelim revenue for AprilN/A
2021-04-14 20:17 ESTNewsBiofrontera AG's (BFRA) CEO Hermann Lübbert on Q4 2020 Results - Earnings Call TranscriptN/A
2021-04-14 02:19 ESTNewsBiofrontera AG (BFRA) CEO Hermann Lübbert on Q4 2020 Results - Earnings Call TranscriptN/A
2021-04-12 14:27 ESTNewsBiofrontera reports Q4 resultsN/A
2021-04-08 22:53 ESTNewsBiofrontera provides preliminary revenue for 1Q21N/A
2021-02-24 20:34 ESTNewsBiofrontera prices $8.9M public offering of ADS; shares down 8%N/A
2021-01-08 12:55 ESTNewsBiofrontera anticipates fiscal year sales of €30.3M, slightly lower from a year agoN/A
2020-12-04 06:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:49 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:52 ESTAnalyst RatingThe Analyst Target Price has increased from $11 to $12.Buy
2020-11-18 06:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 07:29 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 09:51 ESTNewsBiofrontera reports Q3 resultsN/A
2020-10-14 07:41 ESTAnalyst RatingThe Analyst Target Price has decreased from $15.5 to $11.Neutral
2020-10-09 20:02 ESTNewsBiofrontera provides preliminary revenue figuresN/A
2020-10-08 21:10 ESTFinancialsCompany financials have been released.Neutral
2020-10-08 14:04 ESTNewsBiofrontera concludes clinical phase of PK study with Ameluz gel in actinic keratosesN/A
2020-10-04 15:27 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:40 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:19 ESTFinancialsCompany financials have been released.Neutral
2020-09-01 07:51 ESTFinancialsCompany financials have been released.Neutral
2020-08-31 08:35 ESTFinancialsCompany financials have been released.Neutral
2020-08-28 16:50 ESTNewsBiofrontera reports 1H resultsN/A
2020-08-28 16:50 ESTNewsBiofrontera AG (BFRA) CEO Hermann Lübbert on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-14 12:45 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:08 ESTNewsBiofrontera completes convertible debt offeringN/A
2020-08-06 16:28 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:45 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 20:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 08:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 00:51 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 16:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 21:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-15 05:21 ESTNewsBiofrontera reports preliminary H1 salesN/A
2020-07-09 12:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 07:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 23:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 20:15 ESTFinancialsCompany financials have been released.Neutral

About Biofrontera AG (BFRA):

Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma; BF-derm1 for the treatment of chronic and antihistamine-resistant urticaria; and BF-1 for the prophylactic treatment of migraine. Further, the company's product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

BFRA Quotes by TradingView

See Advanced Chart

General

  • Name Biofrontera AG
  • Symbol BFRA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 155
  • Fiscal Year EndDecember
  • IPO Date2018-02-14
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biofrontera.com
View More

Valuation

  • Trailing PE 140.93
  • Price/Sales (Trailing 12 Mt.) 3.48
  • Price/Book (Most Recent Quarter) 27.93
  • Enterprise Value Revenue 5.75
  • Enterprise Value EBITDA 139.28
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.20
  • Profit Margin -51%
  • Return on Assets -8%
  • Return on Equity -256%
  • Earnings Per Share -$0.76
  • Revenue Per Share $0
  • Gross Profit 26.39 million
  • Quarterly Earnings Growth -8.6%
View More

Highlights

  • Market Capitalization 171.37 million
  • Analyst Target Price $12
  • Book Value Per Share $0.68
View More

Share Statistics

  • Shares Outstanding 28.36 million
  • Shares Float 12.47 million
  • % Held by Insiders <1%
  • % Held by Institutions 0.05%
  • Shares Short 14460
  • Shares Short Prior Month 14485
  • Short Ratio 0.17
View More

Technicals

  • Beta 1.44
  • 52 Week High $41.92
  • 52 Week Low $5.26
  • 50 Day Moving Average 7.11
  • 200 Day Moving Average 7.44
View More

Dividends

  • Forward Annual Dividend Yield 0.37%
  • Dividend Date 2021-03-04
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Biofrontera AG (BFRA) Dividend Calendar:

BFRA's last dividend payment was made to shareholders on March 4, 2021.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Biofrontera AG (BFRA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-01-05-$0.33
2020-09-302020-11-11$N/A-$0.28-$0.18-56.95%
2020-06-302020-08-27$N/A$0.05$0.0359.8%
2020-03-312020-04-20$6.47 million-$0.22-$0.247.81%
2019-12-312019-12-31$12.21 million-$0.22-$0.11-100%
2019-09-302019-11-19$5.16 million-$0.58-$0.33-74.49%
2019-06-302019-08-27$7.1 million$0.55-$0.23341.4%
2019-03-312019-04-29$6.81 million$0.18-$0.18202.17%
2018-12-312019-01-22$19.65 million$0.18-$0.13238.46%
2018-09-302018-11-16$6.46 million-$0.23-$0.20-14.84%
2018-06-302018-08-31$5 million-$0.23-$0.241.82%
2018-03-312018-04-28$5.75 million-$0.10-$0.1847.48%

Biofrontera AG (BFRA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A 1.31 million 1.42 million 894000
Income Before Tax N/A N/A -5.5 million -2.25 million -11.55 million
Selling General Administrative N/A N/A 10.93 million 12.39 million 10.78 million
Gross Profit N/A N/A 5.67 million 11.53 million 3.45 million
Ebit N/A N/A -4.99 million -2.19 million -10.46 million
Operating Income N/A N/A -6.57 million -2.28 million -8.23 million
Income Tax Expense 54000 337000 N/A 2.87 million N/A
Total Revenue N/A N/A 6.47 million 12.21 million 5.16 million
Cost of Revenue N/A N/A 799000 682000 1.71 million
Total Other Income Expense Net N/A N/A 1.01 million 357000 -2.41 million
Net Income From Continuing Operations N/A N/A -5.5 million -4.81 million -11.55 million
Net Income Applicable to Common Shares -6.46 million -72000 N/A -5.39 million -12.59 million
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities 56.72 million N/A 46.19 million 48.41 million 58.17 million
Total Stockholder Equity -1.08 million N/A 4.26 million 9.96 million 14.25 million
Other Current Liabilities 3.12 million N/A 2.08 million 183000 9.24 million
Total Assets 55.64 million N/A 50.45 million 58.36 million 72.42 million
Common Stock 44.85 million 44.85 million N/A 44.85 million 44.85 million
Other Current Assets 586000 N/A 1.11 million 1.2 million 1.25 million
Retained Earnings -164.74 million -158.28 million -158.21 million -152.71 million -147.9 million
Other Liabilities 17.34 million 16.96 million N/A 14.72 million 19.66 million
Other Assets 7.48 million 7.48 million N/A 7.79 million 10.4 million
Cash 16.62 million N/A 7.75 million 11.12 million 11.99 million
Total Current Liabilities 8.93 million N/A 9.6 million 11.58 million 16.32 million
Other Stockholder Equity 118.8 million 118.17 million N/A 117.82 million 117.3 million
Property, Plant & Equipment 5.22 million 5.56 million N/A 5.23 million 5.6 million
Total Current Assets 24.04 million N/A 16.72 million 22.49 million 32.44 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets -19.99 million -15.33 million N/A -12.89 million -9.73 million
Short Term Investments 613000 N/A 790000 1.08 million 12.04 million
Long Term Debt 30.45 million N/A 21.93 million 22.11 million 22.19 million
Inventory 4.17 million N/A 4.23 million 4.07 million 4.34 million
Accounts Payable 1.65 million N/A 3.28 million 4.2 million 3.2 million

Biofrontera AG (BFRA) Chart:

Biofrontera AG (BFRA) News:

Below you will find a list of latest news for Biofrontera AG (BFRA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Biofrontera AG (BFRA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Biofrontera AG (BFRA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220012351/0001493152-20-012351-index.htm
2020-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1712641/000121390020006111/0001213900-20-006111-index.htm
2020-08-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1712641/000121390020024238/0001213900-20-024238-index.htm
2020-09-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1712641/000121390020028036/0001213900-20-028036-index.htm
2020-02-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220002969/0001493152-20-002969-index.htm
2020-02-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003010/0001493152-20-003010-index.htm
2020-02-28FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1712641/000149315220003104/0001493152-20-003104-index.htm
2020-03-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003180/0001493152-20-003180-index.htm
2020-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003323/0001493152-20-003323-index.htm
2020-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003412/0001493152-20-003412-index.htm
2020-03-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003479/0001493152-20-003479-index.htm
2020-03-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003480/0001493152-20-003480-index.htm
2020-03-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003481/0001493152-20-003481-index.htm
2020-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003580/0001493152-20-003580-index.htm
2020-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003583/0001493152-20-003583-index.htm
2020-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003586/0001493152-20-003586-index.htm
2020-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003588/0001493152-20-003588-index.htm
2020-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003589/0001493152-20-003589-index.htm
2020-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003590/0001493152-20-003590-index.htm
2020-03-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003655/0001493152-20-003655-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003740/0001493152-20-003740-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003836/0001493152-20-003836-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003844/0001493152-20-003844-index.htm
2020-03-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003864/0001493152-20-003864-index.htm
2020-03-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220003984/0001493152-20-003984-index.htm
2020-03-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220004127/0001493152-20-004127-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220004322/0001493152-20-004322-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220004323/0001493152-20-004323-index.htm
2020-03-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220004390/0001493152-20-004390-index.htm
2020-03-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220004499/0001493152-20-004499-index.htm
2020-03-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220004506/0001493152-20-004506-index.htm
2020-03-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220004779/0001493152-20-004779-index.htm
2020-03-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220004803/0001493152-20-004803-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220005191/0001493152-20-005191-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220005193/0001493152-20-005193-index.htm
2020-04-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220006121/0001493152-20-006121-index.htm
2020-04-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220006158/0001493152-20-006158-index.htm
2020-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220006531/0001493152-20-006531-index.htm
2020-04-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220006597/0001493152-20-006597-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220006694/0001493152-20-006694-index.htm
2020-04-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220006793/0001493152-20-006793-index.htm
2020-04-2120-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1712641/000149315220006857/0001493152-20-006857-index.htm
2020-04-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220006951/0001493152-20-006951-index.htm
2020-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008189/0001493152-20-008189-index.htm
2020-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008190/0001493152-20-008190-index.htm
2020-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008191/0001493152-20-008191-index.htm
2020-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008192/0001493152-20-008192-index.htm
2020-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008193/0001493152-20-008193-index.htm
2020-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008194/0001493152-20-008194-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008327/0001493152-20-008327-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008328/0001493152-20-008328-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008353/0001493152-20-008353-index.htm
2020-05-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008431/0001493152-20-008431-index.htm
2020-05-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008445/0001493152-20-008445-index.htm
2020-05-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008446/0001493152-20-008446-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008792/0001493152-20-008792-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220008794/0001493152-20-008794-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009151/0001493152-20-009151-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009152/0001493152-20-009152-index.htm
2020-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009304/0001493152-20-009304-index.htm
2020-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009307/0001493152-20-009307-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009376/0001493152-20-009376-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009377/0001493152-20-009377-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009456/0001493152-20-009456-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009533/0001493152-20-009533-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009539/0001493152-20-009539-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009831/0001493152-20-009831-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009832/0001493152-20-009832-index.htm
2020-05-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009895/0001493152-20-009895-index.htm
2020-05-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220009896/0001493152-20-009896-index.htm
2020-05-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220010086/0001493152-20-010086-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220012351/0001493152-20-012351-index.htm
2020-07-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220013224/0001493152-20-013224-index.htm
2020-07-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220013849/0001493152-20-013849-index.htm
2020-07-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220014076/0001493152-20-014076-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220014158/0001493152-20-014158-index.htm
2020-08-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220014539/0001493152-20-014539-index.htm
2020-08-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220014541/0001493152-20-014541-index.htm
2020-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220014690/0001493152-20-014690-index.htm
2020-08-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220015048/0001493152-20-015048-index.htm
2020-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220015358/0001493152-20-015358-index.htm
2020-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220015362/0001493152-20-015362-index.htm
2020-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220015364/0001493152-20-015364-index.htm
2020-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220015643/0001493152-20-015643-index.htm
2020-08-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220016141/0001493152-20-016141-index.htm
2020-08-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220016247/0001493152-20-016247-index.htm
2020-08-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220016249/0001493152-20-016249-index.htm
2020-08-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220016466/0001493152-20-016466-index.htm
2020-08-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220016659/0001493152-20-016659-index.htm
2020-08-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220016660/0001493152-20-016660-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220016805/0001493152-20-016805-index.htm
2020-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220016875/0001493152-20-016875-index.htm
2020-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220017455/0001493152-20-017455-index.htm
2020-09-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220017592/0001493152-20-017592-index.htm
2020-09-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220018074/0001493152-20-018074-index.htm
2020-09-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220018076/0001493152-20-018076-index.htm
2020-09-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220018078/0001493152-20-018078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220018209/0001493152-20-018209-index.htm
2020-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220019136/0001493152-20-019136-index.htm
2020-10-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220019202/0001493152-20-019202-index.htm
2020-10-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220019404/0001493152-20-019404-index.htm
2020-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220020165/0001493152-20-020165-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1712641/000149315220020289/0001493152-20-020289-index.htm